Last update :
11/08/2022
Anticancer drug   Idarubicin hydrochloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Idacrybin Mexico
Idamen Turkey
Idamycin Canada, Mexico, United States of America
Idaralem Colombia, Mexico
Ondarubin Mexico
Rubix Mexico
Zavedos Argentina, Australia, Austria, Belgium, Chile, Colombia, Croatia, Denmark, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Italy, Luxembourg, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Republic of South Africa, Romania, Russian, Saudi Arabia, Slovenia, Spain, Sweden, Switzerland, Thailand, Venezuela
Stability in solutions   Injection   Stability in solutions : Idarubicin hydrochloride     
Container Solvent Concentration Temperature Storage Duration References
Polypropylene NaCl 0,9% or Glucose 5% 0,1 mg/ml 25°C Protect from light
28 Day
632
Level of evidence C

Polypropylene Ringer’s lactate solution 0,1 mg/ml 25°C Protect from light
28 Day
632
Level of evidence C

Polypropylen Syringe Water for Injection 4 mg/ml 2-8°C Protect from light
7 Day
4661
Level of evidence A


  Mentions Légales